0001745285-20-000002.txt : 20200403 0001745285-20-000002.hdr.sgml : 20200403 20200403143307 ACCESSION NUMBER: 0001745285-20-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200401 FILED AS OF DATE: 20200403 DATE AS OF CHANGE: 20200403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WIINBERG ULF CENTRAL INDEX KEY: 0001187314 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 20772878 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2020-04-01 0 0001098972 AGENUS INC AGEN 0001187314 WIINBERG ULF C/O AGENUS INC 3 FORBES ROAD LEXINGTON MA 02421 1 0 0 0 Deferred Stock Units 2020-04-01 4 A 0 8009.024 A Common Stock 8009.024 75419.829 D Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the plan, typically once the director ceases to serve as a director of the Company. $3.200 per Deferred Stock Unit acquired on April 1, 2020. The price of each Deferred Stock Unit acquired prior to April 1, 2020 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Agenus Inc. Director Deferred Compensation Plan, as amended. /s/Evan D. Kearns, as Attorney-in-Fact for Ulf Wiinberg 2020-04-03